VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q42789683  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000223.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q42789683‏
024 ‎‡a  0000-0001-5693-5065‏ ‎‡2  orcid‏
024 ‎‡a  55656792000‏ ‎‡2  scopus‏
024 ‎‡a  57195133518‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q42789683‏
100 0 ‎‡a  Jonathan Chang‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Jonathan Chang‏ ‎‡c  researcher (ORCID 0000-0001-5693-5065)‏ ‎‡9  en‏
400 0 ‎‡a  Jonathan Chang‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.‏
670 ‎‡a  Author's Author reply‏
670 ‎‡a  Author's beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy‏
670 ‎‡a  Author's Candida glabrataEndophthalmitis Transmitted From Graft to Host After Descemet Stripping Automated Endothelial Keratoplasty‏
670 ‎‡a  Author's Comparative In Vitro Susceptibility of Besifloxacin and Seven Comparators Against Ciprofloxacin- and Methicillin-Susceptible/Nonsusceptible Staphylococci‏
670 ‎‡a  Author's Cost-effectiveness of retinal detachment repair‏
670 ‎‡a  Author's Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.‏
670 ‎‡a  Author's Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.‏
670 ‎‡a  Author's Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.‏
670 ‎‡a  Author's Cost evaluation of surgical and pharmaceutical options in treatment for vitreomacular adhesions and macular holes‏
670 ‎‡a  Author's Cost-Utility of Evaluation for Posterior Vitreous Detachment and Prophylaxis of Retinal Detachment.‏
670 ‎‡a  Author's Delayed sclerotomy wound dehiscence after lensectomy and vitrectomy in Marfan syndrome‏
670 ‎‡a  Author's Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials‏
670 ‎‡a  Author's Eye drop safety seal causing ocular irritation following cataract and vitrectomy surgery‏
670 ‎‡a  Author's Familial exudative vitreoretinopathy in a premature child.‏
670 ‎‡a  Author's Ghost cell glaucoma following sutureless scleral-fixated posterior chamber intraocular lens placement‏
670 ‎‡a  Author's In Situ Tremor in Vitreoretinal Surgery‏
670 ‎‡a  Author's Long-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat model‏
670 ‎‡a  Author's Management of suprachoroidal 5,000-centistoke silicone oil: two contrasting approaches‏
670 ‎‡a  Author's Marfan's Syndrome with Ectopia Lentis‏
670 ‎‡a  Author's More than just multiple sclerosis‏
670 ‎‡a  Author's Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy‏
670 ‎‡a  Author's Open Payments Database: Anti-Vascular Endothelial Growth Factor Agent Payments to Ophthalmologists.‏
670 ‎‡a  Author's Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy.‏
670 ‎‡a  Author's Optical coherence tomography imaging of chorioretinal folds associated with hypotony maculopathy following pars plana vitrectomy‏
670 ‎‡a  Author's Peripheral corneal ring due to hypercarotenaemia in a case of nutritional supplement abuse‏
670 ‎‡a  Author's Scleral Buckling in the Treatment of Retinal Detachment Due to Retinal Dialysis‏
670 ‎‡a  Author's Spontaneous anatomical and visual improvement in myopic macular retinoschisis‏
670 ‎‡a  Author's Stenotrophomonas maltophilia endophthalmitis following cataract surgery: clinical and microbiological results‏
670 ‎‡a  Author's The Physician Payments Sunshine Act: data evaluation regarding payments to ophthalmologists‏
670 ‎‡a  Author's The Spectrum of Pediatric Orbital BB Gun Injuries: A Case Series.‏
909 ‎‡a  (orcid) 0000000156935065‏ ‎‡9  1‏
909 ‎‡a  (scopus) 55656792000‏ ‎‡9  1‏
909 ‎‡a  (scopus) 57195133518‏ ‎‡9  1‏
912 ‎‡a  authorreply‏ ‎‡A  Author reply‏ ‎‡9  1‏
919 ‎‡a  beta2adrenergicstimulationattenuatesleftventricularremodelingdecreasesapoptosisandimprovescalciumhomeostasisinarodentmodelofischemiccardiomyopathy‏ ‎‡A  beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy‏ ‎‡9  1‏
919 ‎‡a  comparativeinvitrosusceptibilityofbesifloxacinand7comparatorsagainstciprofloxacinandmethicillinsusceptiblenonsusceptiblestaphylococci‏ ‎‡A  Comparative In Vitro Susceptibility of Besifloxacin and Seven Comparators Against Ciprofloxacin- and Methicillin-Susceptible/Nonsusceptible Staphylococci‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofretinaldetachmentrepair‏ ‎‡A  Cost-effectiveness of retinal detachment repair‏ ‎‡9  1‏
919 ‎‡a  costevaluationofearlyvitrectomyversuspanretinalphotocoagulationandintravitrealranibizumabforproliferativediabeticretinopathy‏ ‎‡A  Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.‏ ‎‡9  1‏
919 ‎‡a  costevaluationoflaserversusintravitrealafliberceptforproliferativediabeticretinopathy‏ ‎‡A  Cost Evaluation of Laser versus Intravitreal Aflibercept for Proliferative Diabetic Retinopathy.‏ ‎‡9  1‏
919 ‎‡a  costevaluationofpanretinalphotocoagulationversusintravitrealranibizumabforproliferativediabeticretinopathy‏ ‎‡A  Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.‏ ‎‡9  1‏
919 ‎‡a  costevaluationofsurgicalandpharmaceuticaloptionsintreatmentforvitreomacularadhesionsandmacularholes‏ ‎‡A  Cost evaluation of surgical and pharmaceutical options in treatment for vitreomacular adhesions and macular holes‏ ‎‡9  1‏
919 ‎‡a  costutilityofevaluationforposteriorvitreousdetachmentandprophylaxisofretinaldetachment‏ ‎‡A  Cost-Utility of Evaluation for Posterior Vitreous Detachment and Prophylaxis of Retinal Detachment.‏ ‎‡9  1‏
919 ‎‡a  delayedsclerotomywounddehiscenceafterlensectomyandvitrectomyinmarfansyndrome‏ ‎‡A  Delayed sclerotomy wound dehiscence after lensectomy and vitrectomy in Marfan syndrome‏ ‎‡9  1‏
919 ‎‡a  efficacydurabilityandsafetyofintravitrealfaricimabwithextendeddosinguptoevery16weeksinpatientswithdiabeticmacularoedemayosemiteandrhine2randomiseddoublemaskedphase3trials‏ ‎‡A  Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials‏ ‎‡9  1‏
919 ‎‡a  eyedropsafetysealcausingocularirritationfollowingcataractandvitrectomysurgery‏ ‎‡A  Eye drop safety seal causing ocular irritation following cataract and vitrectomy surgery‏ ‎‡9  1‏
919 ‎‡a  familialexudativevitreoretinopathyinaprematurechild‏ ‎‡A  Familial exudative vitreoretinopathy in a premature child.‏ ‎‡9  1‏
919 ‎‡a  ghostcellglaucomafollowingsuturelessscleralfixatedposteriorchamberintraocularlensplacement‏ ‎‡A  Ghost cell glaucoma following sutureless scleral-fixated posterior chamber intraocular lens placement‏ ‎‡9  1‏
919 ‎‡a  insitutremorinvitreoretinalsurgery‏ ‎‡A  In Situ Tremor in Vitreoretinal Surgery‏ ‎‡9  1‏
919 ‎‡a  longtermeffectsofbtypenatriureticpeptideinfusionafteracutemyocardialinfarctioninaratmodel‏ ‎‡A  Long-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat model‏ ‎‡9  1‏
919 ‎‡a  managementofsuprachoroidal5000centistokesiliconeoil2contrastingapproaches‏ ‎‡A  Management of suprachoroidal 5,000-centistoke silicone oil: two contrasting approaches‏ ‎‡9  1‏
919 ‎‡a  marfanssyndromewithectopialentis‏ ‎‡A  Marfan's Syndrome with Ectopia Lentis‏ ‎‡9  1‏
919 ‎‡a  morethanjustmultiplesclerosis‏ ‎‡A  More than just multiple sclerosis‏ ‎‡9  1‏
919 ‎‡a  neovascularamdwithmarkedmacularfluidandrapidresponsetoantivegftherapy‏ ‎‡A  Neovascular AMD with marked macular fluid and rapid response to anti-VEGF therapy‏ ‎‡9  1‏
919 ‎‡a  openpaymentsdatabaseantivascularendothelialgrowthfactoragentpaymentstoophthalmologists‏ ‎‡A  Open Payments Database: Anti-Vascular Endothelial Growth Factor Agent Payments to Ophthalmologists.‏ ‎‡9  1‏
919 ‎‡a  opticalcoherencetomographyangiographyandultrawidefieldfluoresceinangiographyforearlydetectionofadolescentsickleretinopathy‏ ‎‡A  Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy.‏ ‎‡9  1‏
919 ‎‡a  opticalcoherencetomographyimagingofchorioretinalfoldsassociatedwithhypotonymaculopathyfollowingparsplanavitrectomy‏ ‎‡A  Optical coherence tomography imaging of chorioretinal folds associated with hypotony maculopathy following pars plana vitrectomy‏ ‎‡9  1‏
919 ‎‡a  peripheralcornealringduetohypercarotenaemiainacaseofnutritionalsupplementabuse‏ ‎‡A  Peripheral corneal ring due to hypercarotenaemia in a case of nutritional supplement abuse‏ ‎‡9  1‏
919 ‎‡a  scleralbucklinginthetreatmentofretinaldetachmentduetoretinaldialysis‏ ‎‡A  Scleral Buckling in the Treatment of Retinal Detachment Due to Retinal Dialysis‏ ‎‡9  1‏
919 ‎‡a  spontaneousanatomicalandvisualimprovementinmyopicmacularretinoschisis‏ ‎‡A  Spontaneous anatomical and visual improvement in myopic macular retinoschisis‏ ‎‡9  1‏
919 ‎‡a  stenotrophomonasmaltophiliaendophthalmitisfollowingcataractsurgeryclinicalandmicrobiologicalresults‏ ‎‡A  Stenotrophomonas maltophilia endophthalmitis following cataract surgery: clinical and microbiological results‏ ‎‡9  1‏
919 ‎‡a  physicianpaymentssunshineactdataevaluationregardingpaymentstoophthalmologists‏ ‎‡A  The Physician Payments Sunshine Act: data evaluation regarding payments to ophthalmologists‏ ‎‡9  1‏
919 ‎‡a  spectrumofpediatricorbitalbbguninjuriesacaseseries‏ ‎‡A  The Spectrum of Pediatric Orbital BB Gun Injuries: A Case Series.‏ ‎‡9  1‏
919 ‎‡a  candidaglabrataendophthalmitistransmittedfromgrafttohostafterdescemetstrippingautomatedendothelialkeratoplasty‏ ‎‡A  Candida glabrataEndophthalmitis Transmitted From Graft to Host After Descemet Stripping Automated Endothelial Keratoplasty‏ ‎‡9  1‏
919 ‎‡a  aimingforthebullseyethecostutilityofscreeningforhydroxychloroquineretinopathy‏ ‎‡A  AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  J9U|987007427628805171‏
996 ‎‡2  NII|DA04481862‏
996 ‎‡2  LC|no2014076833‏
996 ‎‡2  LC|n 83187667‏
996 ‎‡2  SUDOC|055305393‏
996 ‎‡2  J9U|987007431489105171‏
996 ‎‡2  NII|DA00810361‏
996 ‎‡2  CYT|AC000116272‏
996 ‎‡2  LNB|LNC10-000180698‏
996 ‎‡2  SUDOC|13589347X‏
996 ‎‡2  LC|nb2006028031‏
996 ‎‡2  ISNI|0000000083028973‏
996 ‎‡2  ISNI|0000000063403879‏
996 ‎‡2  BNF|13490653‏
996 ‎‡2  CAOONL|ncf11467466‏
996 ‎‡2  BIBSYS|90141712‏
996 ‎‡2  LC|nr 94027765‏
996 ‎‡2  ISNI|0000000063876078‏
996 ‎‡2  ISNI|0000000454017764‏
996 ‎‡2  LC|n 85225978‏
996 ‎‡2  ISNI|0000000041348389‏
996 ‎‡2  ISNI|0000000026451716‏
996 ‎‡2  SUDOC|083283293‏
996 ‎‡2  SUDOC|120435608‏
996 ‎‡2  NUKAT|n 2020214422‏
996 ‎‡2  LC|n 82005506‏
996 ‎‡2  ISNI|0000000076598660‏
996 ‎‡2  LC|n 81028541‏
996 ‎‡2  ISNI|0000000063806555‏
996 ‎‡2  ISNI|0000000430780191‏
996 ‎‡2  DNB|1102927082‏
996 ‎‡2  CYT|AC000212225‏
996 ‎‡2  ISNI|0000000064353594‏
996 ‎‡2  BIBSYS|90395089‏
996 ‎‡2  DNB|1204936951‏
996 ‎‡2  LC|n 83171116‏
996 ‎‡2  ISNI|0000000063347643‏
996 ‎‡2  BNF|12195652‏
996 ‎‡2  DNB|111430199X‏
996 ‎‡2  J9U|987007376762005171‏
996 ‎‡2  J9U|987007279575505171‏
996 ‎‡2  LC|no 89000916‏
996 ‎‡2  LC|n 89606172‏
996 ‎‡2  ISNI|0000000453062504‏
996 ‎‡2  ISNI|0000000466730903‏
996 ‎‡2  DNB|128363436‏
996 ‎‡2  ISNI|0000000064318473‏
996 ‎‡2  J9U|987007328547105171‏
996 ‎‡2  LC|nr 93031434‏
996 ‎‡2  LC|nb2004303013‏
996 ‎‡2  SUDOC|092320953‏
996 ‎‡2  ISNI|0000000064131035‏
996 ‎‡2  BNF|14966875‏
996 ‎‡2  SUDOC|233771328‏
996 ‎‡2  BNF|12208800‏
996 ‎‡2  ISNI|0000000408199851‏
996 ‎‡2  DNB|171956338‏
996 ‎‡2  ISNI|0000000371306579‏
996 ‎‡2  BIBSYS|90276563‏
996 ‎‡2  CAOONL|ncf10276951‏
996 ‎‡2  BNF|17140537‏
996 ‎‡2  ISNI|0000000082385880‏
996 ‎‡2  NUKAT|n 2020065235‏
996 ‎‡2  LC|n 90609098‏
996 ‎‡2  ISNI|0000000117508140‏
996 ‎‡2  ISNI|0000000021950903‏
996 ‎‡2  BIBSYS|90336970‏
996 ‎‡2  LC|nr 97037314‏
996 ‎‡2  LC|no2012075310‏
996 ‎‡2  LC|no2020059628‏
996 ‎‡2  LC|no2021144677‏
996 ‎‡2  SUDOC|200494341‏
996 ‎‡2  J9U|987007278552505171‏
996 ‎‡2  LC|nr2002023172‏
996 ‎‡2  ISNI|0000000514225953‏
996 ‎‡2  CYT|AC000196192‏
996 ‎‡2  NTA|406516723‏
996 ‎‡2  LC|n 77020268‏
996 ‎‡2  LC|no 94011505‏
996 ‎‡2  J9U|987007388393305171‏
996 ‎‡2  LC|n 87862889‏
996 ‎‡2  LC|no2011181236‏
996 ‎‡2  LC|n 80068115‏
996 ‎‡2  ISNI|0000000083648320‏
996 ‎‡2  DNB|172018250‏
996 ‎‡2  LC|n 2009028712‏
996 ‎‡2  ISNI|0000000063562204‏
996 ‎‡2  LC|n 82271056‏
996 ‎‡2  LC|no2004088116‏
996 ‎‡2  BNF|17053457‏
996 ‎‡2  LC|n 88004945‏
996 ‎‡2  ISNI|0000000064248022‏
996 ‎‡2  LC|n 87862982‏
996 ‎‡2  PLWABN|9812451084305606‏
996 ‎‡2  ISNI|0000000066617039‏
996 ‎‡2  ISNI|0000000063816083‏
996 ‎‡2  LC|n 97097706‏
996 ‎‡2  LC|n 2022038559‏
996 ‎‡2  LC|n 81020920‏
996 ‎‡2  J9U|987009748068905171‏
996 ‎‡2  CYT|AC000176457‏
996 ‎‡2  RERO|A003094679‏
996 ‎‡2  ISNI|0000000063416223‏
996 ‎‡2  LC|no2015164672‏
996 ‎‡2  LC|no2022130748‏
996 ‎‡2  NUKAT|nx2022488920‏
996 ‎‡2  LC|n 82258795‏
996 ‎‡2  NTA|14516036X‏
996 ‎‡2  ISNI|0000000091117749‏
996 ‎‡2  NTA|069586187‏
996 ‎‡2  LC|n 82033114‏
996 ‎‡2  BNF|13605728‏
996 ‎‡2  CAOONL|ncf10181893‏
996 ‎‡2  ISNI|0000000059783637‏
996 ‎‡2  LC|n 81005831‏
996 ‎‡2  ISNI|0000000050258123‏
996 ‎‡2  CYT|AC000229012‏
996 ‎‡2  RERO|A027753892‏
996 ‎‡2  J9U|987007461196805171‏
996 ‎‡2  LC|nr2003038672‏
996 ‎‡2  ISNI|0000000436228058‏
996 ‎‡2  LC|n 85055694‏
996 ‎‡2  LC|no 97024927‏
996 ‎‡2  LC|no2015000460‏
996 ‎‡2  CAOONL|ncf10730228‏
996 ‎‡2  J9U|987007448430205171‏
996 ‎‡2  LC|no2012058017‏
996 ‎‡2  ISNI|0000000067285291‏
996 ‎‡2  ISNI|0000000053503526‏
996 ‎‡2  NKC|ntk20191055346‏
996 ‎‡2  BIBSYS|3039203‏
996 ‎‡2  NLA|000035820528‏
996 ‎‡2  NTA|364176520‏
996 ‎‡2  J9U|987007430579805171‏
996 ‎‡2  LC|no2014096777‏
996 ‎‡2  BIBSYS|3104235‏
996 ‎‡2  LC|no2008185554‏
996 ‎‡2  NUKAT|n 93120209‏
996 ‎‡2  ISNI|0000000064016803‏
996 ‎‡2  ISNI|0000000499534044‏
996 ‎‡2  ISNI|0000000459642606‏
996 ‎‡2  LC|n 2005028517‏
996 ‎‡2  PLWABN|9814010389005606‏
996 ‎‡2  DNB|1053699662‏
996 ‎‡2  LC|n 83003974‏
996 ‎‡2  CYT|AC000001056‏
996 ‎‡2  SUDOC|103627553‏
996 ‎‡2  ISNI|0000000063454350‏
996 ‎‡2  LC|no2013107037‏
996 ‎‡2  SUDOC|081273681‏
996 ‎‡2  NDL|00435697‏
996 ‎‡2  DNB|1076493041‏
996 ‎‡2  PLWABN|9810616031205606‏
996 ‎‡2  LC|n 85031833‏
996 ‎‡2  SUDOC|069147566‏
996 ‎‡2  DNB|131269615X‏
996 ‎‡2  NTA|306710447‏
996 ‎‡2  ISNI|0000000064022875‏
996 ‎‡2  DNB|101215291X‏
996 ‎‡2  J9U|987007407470205171‏
996 ‎‡2  SELIBR|262609‏
996 ‎‡2  ISNI|0000000043113225‏
996 ‎‡2  LC|n 89129526‏
996 ‎‡2  ISNI|0000000063412732‏
996 ‎‡2  DNB|119044854‏
996 ‎‡2  ISNI|0000000063350957‏
996 ‎‡2  PLWABN|9814233201805606‏
996 ‎‡2  NII|DA09785616‏
996 ‎‡2  DNB|1245464884‏
996 ‎‡2  ISNI|0000000473623057‏
996 ‎‡2  LC|nr 89013107‏
996 ‎‡2  CYT|AC000228044‏
996 ‎‡2  J9U|987007376733005171‏
996 ‎‡2  CAOONL|ncf11431506‏
996 ‎‡2  LC|n 00047031‏
996 ‎‡2  ISNI|0000000063416784‏
996 ‎‡2  LC|no2014099167‏
996 ‎‡2  NTA|152085289‏
996 ‎‡2  SUDOC|050185748‏
996 ‎‡2  ISNI|0000000066557240‏
996 ‎‡2  ISNI|0000000063792149‏
996 ‎‡2  DNB|1286862884‏
996 ‎‡2  LIH|LNB:BP_x__l_;=CG‏
996 ‎‡2  ISNI|0000000079905873‏
996 ‎‡2  ISNI|0000000064031587‏
996 ‎‡2  LC|n 81068368‏
996 ‎‡2  LC|n 2023070716‏
996 ‎‡2  LC|n 88263048‏
996 ‎‡2  ISNI|0000000122376568‏
996 ‎‡2  LC|n 2018005083‏
996 ‎‡2  LC|nr 99009553‏
996 ‎‡2  LC|n 86013032‏
996 ‎‡2  SUDOC|030730716‏
996 ‎‡2  CAOONL|ncf11718439‏
996 ‎‡2  LC|nb2003007939‏
996 ‎‡2  SUDOC|257178872‏
996 ‎‡2  ISNI|0000000040687928‏
996 ‎‡2  ISNI|0000000064271601‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏